๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cost-effectiveness analysis of exemestane compared with megestrol in patients with advanced breast carcinoma

โœ Scribed by Bruce E. Hillner; Davide Radice


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
80 KB
Volume
91
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Effects of high dose raloxifene in selec
โœ William Gradishar; Joan Glusman; Yili Lu; Charles Vogel; Fredric J. Cohen; Georg ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 78 KB ๐Ÿ‘ 1 views

BACKGROUND. An earlier trial of raloxifene, conducted in women with metastatic breast carcinoma who initially had responded to tamoxifen and subsequently developed disease progression, suggested no antitumor activity for raloxifene in tamoxifen-refractory disease. However, preclinical studies and pr

Pharmacoeconomic profile of paclitaxel a
โœ Andrea Messori; Michele Cecchi; Paola Becagli; Sabrina Trippoli ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 61 KB ๐Ÿ‘ 1 views

medullary recurrence in certain ethnic groups will be the field have read the article. I agree that there is no proof that all-trans retinoic acid (ATRA) therapy confirmed by further observation and analysis of recurrence in the large cooperative group studying APL. predisposes patients to the deve

A Phase II trial of high dose epirubicin
โœ Kathy D. Miller; Nikhil Munshi; David Loesch; Lawrence H. Einhorn; George W. Sle ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 82 KB ๐Ÿ‘ 2 views

## BACKGROUND. Anthracyclines are among the most active drugs in the treatment of breast carcinoma and exhibit a steep dose-response curve in vitro. This trial was performed to determine the efficacy and toxicity of epirubicin in the treatment of patients with advanced breast carcinoma when adminis